Search

Your search keyword '"Leonardi, G."' showing total 1,012 results
Start Over Author "Leonardi, G." Publication Year Range Last 50 years
1,012 results on '"Leonardi, G."'

8. Industrial lignins as efficient biosorbents for Cr(vi) water remediation: transforming a waste into an added value material

Author

Vescovi, M, Melegari, M, Gazzurelli, C, Maffini, M, Mucchino, C, Mazzeo, P, Carcelli, M, Perego, J, Migliori, A, Leonardi, G, Pietarinen, S, Pelagatti, P, Rogolino, D, Vescovi M., Melegari M., Gazzurelli C., Maffini M., Mucchino C., Mazzeo P. P., Carcelli M., Perego J., Migliori A., Leonardi G., Pietarinen S., Pelagatti P., Rogolino D., Vescovi, M, Melegari, M, Gazzurelli, C, Maffini, M, Mucchino, C, Mazzeo, P, Carcelli, M, Perego, J, Migliori, A, Leonardi, G, Pietarinen, S, Pelagatti, P, Rogolino, D, Vescovi M., Melegari M., Gazzurelli C., Maffini M., Mucchino C., Mazzeo P. P., Carcelli M., Perego J., Migliori A., Leonardi G., Pietarinen S., Pelagatti P., and Rogolino D.

Abstract

Cr(vi) represents a worldwide issue due to its carcinogenicity and toxicity, and its removal from water/waste-water is of great relevance for the protection of human health and the environment. We here present an investigation of the adsorption and reduction properties towards Cr(vi) of two different kinds of industrial lignins: a kraft softwood lignin (HMW) and a hardwood lignin (EH) obtained by an enzymatic process. Moreover, we prepared and characterized an acetylated and a phosphorylated lignin starting from HMW, along with a lignin@magnetite hybrid material. The influence of various experimental parameters on the adsorption process, such as pH, contact time, quantity of lignin, Cr(vi) concentration and ionic strength, was evaluated. The best performances can be obtained at acidic pH (pH = 2). With an initial Cr(vi) concentration of 20 mg L−1 and a contact time of 24 hours, a quantitative Cr(vi) reduction was observed, accompanied by a removal of total chromium of up to 35% when HMW was used as the biosorbent. A comparison of the adsorption profiles of the different biosorbents highlighted the higher performance of EH, endowed with a higher surface area and characterised by a maximum adsorption capacity of about 208 mg g−1, while acetylation of the hydroxyl group led to a drop in the adsorption profile. The best fitting of the adsorption isotherm by using the Langmuir model suggests that a monolayer coverage of metal ions onto the homogeneous active sites of the lignin's surface better describes the interactions occurring at the biosorbent interface. Overall, this study demonstrates that technical lignins, and particularly EH hardwood lignin, are effective and economic materials that could be successfully employed in the Cr(vi) water remediation process.

Published
2023

9. Injections intramusculaires de toxine botulique pour le traitement du syndrome de douleur myofasciale du haut du dos : une revue systématique des essais contrôlés randomisés.

Author

Leonardi, G., Alito, A., Portaro, S., Di Matteo, B., Respizzi, S., Kon, E., Massazza, G., Sconza, C., and Leroy, B.

Subjects
*BOTULINUM toxin, *BOTULINUM A toxins, *SALINE solutions, *PAIN management, *RANDOMIZED controlled trials, *MYOFASCIAL pain syndromes
Abstract

Background and Objective: Myofascial pain syndrome (MPS) is a chronic musculoskeletal disorder characterized by the presence of trigger points. Among the treatment options, botulinum toxin injections have been investigated. The aim of this paper was to provide a synthesis of the evidence on intramuscular botulinum toxin injections for upper back MPS. Databases and Data Treatment: A systematic review of the literature was performed on the PubMed, Scopus and Cochrane Library, using the following formula: ("botulinum") AND ("musculoskeletal") AND ("upper back pain") OR ("myofascial pain"). Results: Ten studies involving 651 patients were included. Patients in the control groups received placebo (saline solution) injections, anaesthetic injections + dry needling or anaesthetic injections. The analysis of the trials revealed modest methodological quality: one "Good quality" study, one "Fair" and the other "Poor". No major complications or serious adverse events were reported. Results provided conflicting evidence and did not demonstrate the superiority of botulinum toxin over comparators. Most of the included trials were characterized by a small sample size, weak power analysis, different clinical scores used and non-comparable follow-up periods. Even if there is no conclusive evidence, the favourable safety profile and the positive results of some secondary endpoints suggest a potentially beneficial action in pain control and quality of life. Conclusion: The currently available studies show conflicting results. Their overall low methodological quality does not allow for solid evidence of superiority over other comparison treatments. Further insights are needed to properly profile patients who could benefit more from this peculiar injective approach. Significance: The randomized controlled trials included in this review compared using botulinum toxin to treat upper back MPS with placebo or active treatments (e.g., dry needling or anaesthetics) showing mixed results overall. Despite the lack of clear evidence of superiority, our study suggests that the use of botulinum toxin should not be discouraged. Its safety profile and encouraging results in pain control, motor recovery and disability reduction make it an interesting treatment, particularly in the subset of patients with moderate to severe chronic pain and active trigger points. To support the safety and efficacy of botulinum toxin, further high-quality studies are needed. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

10. Intramuscular injections of botulinum toxin for the treatment of upper back myofascial pain syndrome: A systematic review of randomized controlled trials.

Author

Leonardi, G., Alito, A., Portaro, S., Di Matteo, B., Respizzi, S., Kon, E., Massazza, G., and Sconza, C.

Abstract

Background and Objective: Myofascial pain syndrome (MPS) is a chronic musculoskeletal disorder characterized by the presence of trigger points. Among the treatment options, botulinum toxin injections have been investigated. The aim of this paper was to provide a synthesis of the evidence on intramuscular botulinum toxin injections for upper back MPS. Databases and Data Treatment: A systematic review of the literature was performed on the PubMed, Scopus and Cochrane Library, using the following formula: ("botulinum") AND ("musculoskeletal") AND ("upper back pain") OR ("myofascial pain"). Results: Ten studies involving 651 patients were included. Patients in the control groups received placebo (saline solution) injections, anaesthetic injections + dry needling or anaesthetic injections. The analysis of the trials revealed modest methodological quality: one "Good quality" study, one "Fair" and the other "Poor". No major complications or serious adverse events were reported. Results provided conflicting evidence and did not demonstrate the superiority of botulinum toxin over comparators. Most of the included trials were characterized by a small sample size, weak power analysis, different clinical scores used and non‐comparable follow‐up periods. Even if there is no conclusive evidence, the favourable safety profile and the positive results of some secondary endpoints suggest a potentially beneficial action in pain control and quality of life. Conclusion: The currently available studies show conflicting results. Their overall low methodological quality does not allow for solid evidence of superiority over other comparison treatments. Further insights are needed to properly profile patients who could benefit more from this peculiar injective approach. Significance: The randomized controlled trials included in this review compared using botulinum toxin to treat upper back MPS with placebo or active treatments (e.g., dry needling or anaesthetics) showing mixed results overall. Despite the lack of clear evidence of superiority, our study suggests that the use of botulinum toxin should not be discouraged. Its safety profile and encouraging results in pain control, motor recovery and disability reduction make it an interesting treatment, particularly in the subset of patients with moderate to severe chronic pain and active trigger points. To support the safety and efficacy of botulinum toxin, further high‐quality studies are needed. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

14. FRONTLINE INTENSIFIED ABVD DEMONSTRATES SUPERIOR EFFICACY THAN PET‐ADAPTED ABVD IN ADVANCED HODGKIN LYMPHOMA: THE FIL‐ROUGE PHASE 3 TRIAL BY THE FONDAZIONE ITALIANA LINFOMI

Author

Pinto, A., primary, Corazzelli, G., additional, Evangelista, A., additional, Patti, C., additional, De Lorenzo, S., additional, Re, A., additional, Merli, F., additional, Botto, B., additional, Tarantini, G., additional, Guarini, A., additional, Leonardi, G., additional, Hohaus, S., additional, Cavallo, F., additional, Pulsoni, A., additional, Gotti, M., additional, Celli, M., additional, Gaudio, F., additional, Ricci, F., additional, Liberati, A. M., additional, Pavone, V., additional, Rota‐Scalabrini, D., additional, Flenghi, L., additional, Arcari, A., additional, Cimminiello, M., additional, Zilioli, V. R., additional, Morelli, E., additional, Mulè, A., additional, Arcamone, M., additional, Pagani, C., additional, Arletti, L., additional, Levis, M., additional, De Filippi, R., additional, Cuccaro, A., additional, Cesaretti, M., additional, Borgo, E., additional, Musto, P., additional, Vitolo, U., additional, Chauvie, S., additional, Ricardi, U., additional, Ciccone, G., additional, and Santoro, A., additional

Published
2023
Full Text
View/download PDF

17. Atmospheric plasma treatments of cashmere: The role of nanoscale sizing in the spray coating processing

Author

Barni, R, Roman, H, Citterio, A, Leonardi, G, Riccardi, C, Barni R., Roman H. E., Citterio A., Leonardi G., Riccardi C., Barni, R, Roman, H, Citterio, A, Leonardi, G, Riccardi, C, Barni R., Roman H. E., Citterio A., Leonardi G., and Riccardi C.

Abstract

We discuss the effects of air atmospheric plasma interaction with the surface of a textile. We studied how plasma can promote changes in its texture and roughness at nano- and micro-meter scales, having an impact on the improvement of such macroscopic properties as hydro/oleo-repellency and pilling, without altering the hand assessment quality of the textile. These results are obtained by analyzing images taken using electron microscopy. We studied both the fluctuations of the image intensity at the fiber surfaces and their Fourier transforms at the sub-micrometer scales. As a case study, we have analyzed the modifications of a cashmere fabric and the improvement of finishing using resin spray coating. We observe a better efficiency when resin is applied to a plasma-treated sample. This result has been traced to the modifications that plasma induces on the surface at the nanoscale. This opens up wide perspectives to the use of plasma technology for the whole textile industrial sector.

Published
2022

18. Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma

Author

Karaca Atabay, E, Mecca, C, Wang, Q, Ambrogio, C, Mota, I, Prokoph, N, Mura, G, Martinengo, C, Patrucco, E, Leonardi, G, Hossa, J, Pich, A, Mologni, L, Gambacorti Passerini, C, Brugieres, L, Geoerger, B, Turner, S, Voena, C, Cheong, T, Chiarle, R, Karaca Atabay E., Mecca C., Wang Q., Ambrogio C., Mota I., Prokoph N., Mura G., Martinengo C., Patrucco E., Leonardi G., Hossa J., Pich A., Mologni L., Gambacorti Passerini C., Brugieres L., Geoerger B., Turner S. D., Voena C., Cheong T. -C., Chiarle R., Karaca Atabay, E, Mecca, C, Wang, Q, Ambrogio, C, Mota, I, Prokoph, N, Mura, G, Martinengo, C, Patrucco, E, Leonardi, G, Hossa, J, Pich, A, Mologni, L, Gambacorti Passerini, C, Brugieres, L, Geoerger, B, Turner, S, Voena, C, Cheong, T, Chiarle, R, Karaca Atabay E., Mecca C., Wang Q., Ambrogio C., Mota I., Prokoph N., Mura G., Martinengo C., Patrucco E., Leonardi G., Hossa J., Pich A., Mologni L., Gambacorti Passerini C., Brugieres L., Geoerger B., Turner S. D., Voena C., Cheong T. -C., and Chiarle R.

Abstract

Anaplastic large cell lymphomas (ALCLs) frequently carry oncogenic fusions involving the anaplastic lymphoma kinase (ALK) gene. Targeting ALK using tyrosine kinase inhibitors (TKIs) is a therapeutic option in cases relapsed after chemotherapy, but TKI resistance may develop. By applying genomic loss-of-function screens, we identified PTPN1 and PTPN2 phosphatases as consistent top hits driving resistance to ALK TKIs in ALK+ ALCL. Loss of either PTPN1 or PTPN2 induced resistance to ALK TKIs in vitro and in vivo. Mechanistically, we demonstrated that PTPN1 and PTPN2 are phosphatases that bind to and regulate ALK phosphorylation and activity. In turn, oncogenic ALK and STAT3 repress PTPN1 transcription. We found that PTPN1 is also a phosphatase for SHP2, a key mediator of oncogenic ALK signaling. Downstream signaling analysis showed that deletion of PTPN1 or PTPN2 induces resistance to crizotinib by hyperactivating SHP2, the MAPK, and JAK/STAT pathways. RNA sequencing of patient samples that developed resistance to ALK TKIs showed downregulation of PTPN1 and PTPN2 associated with upregulation of SHP2 expression. Combination of crizotinib with a SHP2 inhibitor synergistically inhibited the growth of wild-type or PTPN1/PTPN2 knock-out ALCL, where it reverted TKI resistance. Thus, we identified PTPN1 and PTPN2 as ALK phosphatases that control sensitivity to ALK TKIs in ALCL and demonstrated that a combined blockade of SHP2 potentiates the efficacy of ALK inhibition in TKI-sensitive and -resistant ALK+ ALCL.

Published
2022

19. Discrete Varifolds: A Unified Framework for Discrete Approximations of Surfaces and Mean Curvature

Author

Buet, B., Leonardi, G. P., Masnou, S., Hutchison, David, Series editor, Kanade, Takeo, Series editor, Kittler, Josef, Series editor, Kleinberg, Jon M., Series editor, Mattern, Friedemann, Series editor, Mitchell, John C., Series editor, Naor, Moni, Series editor, Pandu Rangan, C., Series editor, Steffen, Bernhard, Series editor, Terzopoulos, Demetri, Series editor, Tygar, Doug, Series editor, Weikum, Gerhard, Series editor, Aujol, Jean-François, editor, Nikolova, Mila, editor, and Papadakis, Nicolas, editor

Published
2015
Full Text
View/download PDF

20. P275 COMBINED NEURO–HUMORAL MODULATION AND OUTCOME IN PATIENTS WITH CHRONIC HEART FAILURE AND MILDLY REDUCED OR PRESERVED EJECTION FRACTION

Author

Gori, M, primary, Marini, M, additional, Gonzini, L, additional, Carigi, S, additional, De Gennaro, L, additional, Gentile, P, additional, Leonardi, G, additional, Orso, F, additional, Tinti, D, additional, Lucci, D, additional, Iacoviello, M, additional, Navazio, A, additional, Ammirati, E, additional, Municinò, A, additional, Benvenuto, M, additional, Cassaniti, L, additional, Tavazzi, L, additional, Maggioni, A, additional, and De Maria, R, additional

Published
2023
Full Text
View/download PDF

21. The practical management of chronic constipation as detected by a survey conducted on Italian gastroenterologists

Author

Fabbri, Carlo, Spada, Cristiano, Aragona, S. E., Ciprandi, Guido, Alberico, G., Antoniazzi, S., Arrigoni, A., Astegiano, M., Astretto, S., Baroni, S., Battaglia, E., Belcari, C., Beretta, P., Bianchetti, Maddalena, Bianchi, M. L., Bindi, B., Buda, C., Camilleri, S., Caronna, S., Cautela, G., Cavallaro, Fabio, Cocco, A., Colucci, R., Consalvo, D., Cordone, G., Cortelezzi, C., Cozzoli, G., Curro, E. A., Damiani, Andrea, D'Amore, F., De Falco, P., De Girolamo, Maria Vittoria, De Luca, L., Di Lorenzo, F., Di Marzo, S., Di Nardo, G., Ferrara, M., Fiaccavento, R., Fina, D., Frasca, R., Gallo, M., Gennarelli, N., Ghittoni, G., Giangregorio, F., Giannetti, A., Giglio, L. A., Giuncato, S., Grosso, S., Iannuzziello, D., Ibba, I., Incarbone, S., La Spada, S., Lagoussis, P., Lecca, G., Leonardi, G., Licari, G., Lucia, Mothanje Barbara Patricia, Lupinacci, G., Magri, S., Oppezzi, M., Paiano, P., Palombo, V., Pardocchi, D., Parodi, A., Pati, A., Petrini, C., Pinto, A., Pirrotta, P., Piscopo, A., Polimeni, N., Preatoni, P., Quintigliano, D., Radice, E., Ricco, G., Rodella, Luigi Fabrizio, Schettino, M., Schettino, Paola, Schicchi, A. A., Schiffino, L., Severi, C., Sinagra, E., Tarantello, M., Valeri, Giovanni, Vanni, R., Vinti, M., Zulli, C., Fabbri C., Spada C. (ORCID:0000-0002-5692-0960), Ciprandi G., Bianchetti M., Cavallaro F., Damiani A., De Girolamo V., Lucia M. (ORCID:0000-0001-7648-2198), Rodella L., Schettino P., Valeri G., Fabbri, Carlo, Spada, Cristiano, Aragona, S. E., Ciprandi, Guido, Alberico, G., Antoniazzi, S., Arrigoni, A., Astegiano, M., Astretto, S., Baroni, S., Battaglia, E., Belcari, C., Beretta, P., Bianchetti, Maddalena, Bianchi, M. L., Bindi, B., Buda, C., Camilleri, S., Caronna, S., Cautela, G., Cavallaro, Fabio, Cocco, A., Colucci, R., Consalvo, D., Cordone, G., Cortelezzi, C., Cozzoli, G., Curro, E. A., Damiani, Andrea, D'Amore, F., De Falco, P., De Girolamo, Maria Vittoria, De Luca, L., Di Lorenzo, F., Di Marzo, S., Di Nardo, G., Ferrara, M., Fiaccavento, R., Fina, D., Frasca, R., Gallo, M., Gennarelli, N., Ghittoni, G., Giangregorio, F., Giannetti, A., Giglio, L. A., Giuncato, S., Grosso, S., Iannuzziello, D., Ibba, I., Incarbone, S., La Spada, S., Lagoussis, P., Lecca, G., Leonardi, G., Licari, G., Lucia, Mothanje Barbara Patricia, Lupinacci, G., Magri, S., Oppezzi, M., Paiano, P., Palombo, V., Pardocchi, D., Parodi, A., Pati, A., Petrini, C., Pinto, A., Pirrotta, P., Piscopo, A., Polimeni, N., Preatoni, P., Quintigliano, D., Radice, E., Ricco, G., Rodella, Luigi Fabrizio, Schettino, M., Schettino, Paola, Schicchi, A. A., Schiffino, L., Severi, C., Sinagra, E., Tarantello, M., Valeri, Giovanni, Vanni, R., Vinti, M., Zulli, C., Fabbri C., Spada C. (ORCID:0000-0002-5692-0960), Ciprandi G., Bianchetti M., Cavallaro F., Damiani A., De Girolamo V., Lucia M. (ORCID:0000-0001-7648-2198), Rodella L., Schettino P., and Valeri G.

Abstract

BACKGROUND: Chronic constipation represents a widespread medical condition, mainly in elderly people. The management is compelling as these patients frequently have comorbidity and polypharmacy. Polyethylene glycol (PEG) is commonly used but does not resolve some complaints, mainly concerning pain and bloating. Therefore, a new medical device containing PEG plus simethicone, an antifoaming agent, has been developed. The present survey explored its use in clinical practice. METHODS: A group of 64 Italian gastroenterologists visited 2426 patients with chronic primary constipation. In about two/third, gastroenterologists freely prescribed the new medical device, and in the remaining patients, other treatments were freely chosen by doctors. Patients were followed up for three months. The number of evacuations, stool characteristics, patients’ perception of illness assessed by VAS, frequency of patients with pain and intestinal symptoms, and discontinuing patients was observed during the experience. RESULTS: The new medical device was significantly better than other therapies in improving all parameters (P<0.05 for all parameters). CONCLUSIONS: The present survey demonstrated that a new medical device containing PEG plus simethicone represents a favorable option in managing patients with chronic primary constipation as significantly and safely improves intestinal transit, reduces stool consistency, reduces symptom severity, and is highly satisfactory.

Published
2023

27. Atmospheric plasma treatments of cashmere: The role of nanoscale sizing in the spray coating processing

Author

Barni, R., Roman, H. E., Citterio, A., Leonardi, G., Riccardi, C., Barni, R, Roman, H, Citterio, A, Leonardi, G, and Riccardi, C

Subjects
plasma processing, FIS/01 - FISICA SPERIMENTALE, nanostructure, Materials Science (miscellaneous), spray coating, cashmere, atmospheric pressure plasma, textile finishing
Abstract

We discuss the effects of air atmospheric plasma interaction with the surface of a textile. We studied how plasma can promote changes in its texture and roughness at nano- and micro-meter scales, having an impact on the improvement of such macroscopic properties as hydro/oleo-repellency and pilling, without altering the hand assessment quality of the textile. These results are obtained by analyzing images taken using electron microscopy. We studied both the fluctuations of the image intensity at the fiber surfaces and their Fourier transforms at the sub-micrometer scales. As a case study, we have analyzed the modifications of a cashmere fabric and the improvement of finishing using resin spray coating. We observe a better efficiency when resin is applied to a plasma-treated sample. This result has been traced to the modifications that plasma induces on the surface at the nanoscale. This opens up wide perspectives to the use of plasma technology for the whole textile industrial sector.

Published
2022

28. Design Patterns of Technology-based Therapeutic Activities for Children with Language Impairments: A Psycholinguistic-Driven Approach

Author

Kitamura, Y, Quigley, A, Isbister, K, Igarash, T, Spitale, M, Silleresi, S, Leonardi, G, Arosio, F, Giustolisi, B, Guasti, M, Garzotto, F, Spitale M., Silleresi S., Leonardi G., Arosio F., Giustolisi B., Guasti M. T., Garzotto F., Kitamura, Y, Quigley, A, Isbister, K, Igarash, T, Spitale, M, Silleresi, S, Leonardi, G, Arosio, F, Giustolisi, B, Guasti, M, Garzotto, F, Spitale M., Silleresi S., Leonardi G., Arosio F., Giustolisi B., Guasti M. T., and Garzotto F.

Abstract

In the last years, researchers and therapists have pinpointed a number of critical aspects in current speech-language interventions. Several studies have explored the use of technology to overcome these barriers and to support speech-therapy in children with language impairments (e.g. DLD and ASD). In this paper, we propose a conceptual framework for designing linguistic activities (for assessment and training), based on advances in psycholinguistics. Moving from this theoretical framework, we identified a development process - from the UX design to coding of activities - which is based on a novel set of Design Patterns at multiple layers of abstraction. We then put this framework into practice by implementing these patterns into two technological solutions - tablet and robots - and performing an empirical study to evaluate their benefits. Our results, although still preliminary since they assessed only a tablet experimental condition, are promising for extending the identified Design Patterns to other technological solutions.

Published
2021

30. 32nd International Austrian Winter Symposium: Zell am See, the Netherlands. 20-23 January 2016

Author

Langsteger, W, Rezaee, A, Loidl, W, Geinitz, HS, Fitz, F, Steinmair, M, Broinger, G, Pallwien-Prettner, L, Beheshti, M, Imamovic, L, Beheshti, M, Rendl, G, Hackl, D, Tsybrovsky, O, Steinmair, M, Emmanuel, K, Moinfar, F, Pirich, C, Langsteger, W, Bytyqi, A, Karanikas, G, Mayerhöfer, M, Koperek, O, Niederle, B, Hartenbach, M, Beyer, T, Herrmann, K, Czernin, J, Rausch, I, Rust, P, DiFranco, MD, Lassen, M, Stadlbauer, A, Mayerhöfer, ME, Hartenbach, M, Hacker, M, Beyer, T, Binzel, K, Magnussen, R, Wei, W, Knopp, MU, Flanigan, DC, Kaeding, C, Knopp, MV, Leisser, A, Nejabat, M, Hartenbach, M, Kramer, G, Krainer, M, Hacker, M, Haug, A, Lehnert, Wencke, Schmidt, Karl, Kimiaei, Sharok, Bronzel, Marcus, Kluge, Andreas, Wright, CL, Binzel, K, Zhang, J, Wuthrick, Evan, Maniawski, Piotr, Knopp, MV, Blaickner, M, Rados, E, Huber, A, Dulovits, M, Kulkarni, H, Wiessalla, S, Schuchardt, C, Baum, RP, Knäusl, B, Georg, D, Bauer, M, Wulkersdorfer, B, Wadsak, W, Philippe, C, Haslacher, H, Zeitlinger, M, Langer, O, Bauer, M, Feldmann, M, Karch, R, Wadsak, W, Zeitlinger, M, Koepp, MJ, Asselin, M-C, Pataraia, E, Langer, O, Zeilinger, M, Philippe, C, Dumanic, M, Pichler, F, Pilz, J, Hacker, M, Wadsak, W, Mitterhauser, M, Nics, L, Steiner, B, Hacker, M, Mitterhauser, M, Wadsak, W, Traxl, A, Wanek, Thomas, Kryeziu, Kushtrim, Mairinger, Severin, Stanek, Johann, Berger, Walter, Kuntner, Claudia, Langer, Oliver, Mairinger, S, Wanek, T, Traxl, A, Krohn, M, Stanek, J, Filip, T, Sauberer, M, Kuntner, C, Pahnke, J, Langer, O, Svatunek, D, Denk, C, Wilkovitsch, M, Wanek, T, Filip, T, Kuntner-Hannes, C, Fröhlich, J, Mikula, H, Denk, C, Svatunek, D, Wanek, T, Mairinger, S, Stanek, J, Filip, T, Fröhlich, J, Mikula, H, Kuntner-Hannes, C, Balber, T, Singer, J, Fazekas, J, Rami-Mark, C, Berroterán-Infante, N, Jensen-Jarolim, E, Wadsak, W, Hacker, M, Viernstein, H, Mitterhauser, M, Denk, C, Svatunek, D, Sohr, B, Mikula, H, Fröhlich, J, Wanek, T, Kuntner-Hannes, C, Filip, T, Pfaff, S, Philippe, C, Mitterhauser, M, Hartenbach, M, Hacker, M, Wadsak, W, Wanek, T, Halilbasic, E, Visentin, M, Mairinger, S, Stieger, B, Kuntner, C, Trauner, M, Langer, O, Lam, P, Aistleitner, M, Eichinger, R, Artner, C, Eidherr, H, Vraka, C, Haug, A, Mitterhauser, M, Nics, L, Hartenbach, M, Hacker, M, Wadsak, W, Kvaternik, H, Müller, R, Hausberger, D, Zink, C, Aigner, RM, Cossío, U, Asensio, M, Montes, A, Akhtar, S, te Welscher, Y, van Nostrum, R, Gómez-Vallejo, V, Llop, J, VandeVyver, F, Barclay, T, Lippens, N, Troch, M, Hehenwarter, L, Egger, B, Holzmannhofer, J, Rodrigues-Radischat, M, Pirich, C, Pötsch, N, Rausch, I, Wilhelm, D, Weber, M, Furtner, J, Karanikas, G, Wöhrer, A, Mitterhauser, M, Hacker, M, Traub-Weidinger, T, Cassou-Mounat, T, Balogova, S, Nataf, V, Calzada, M, Huchet, V, Kerrou, K, Devaux, J-Y, Mohty, M, Garderet, L, Talbot, J-N, Stanzel, S, Pregartner, G, Schwarz, T, Bjelic-Radisic, V, Liegl-Atzwanger, B, Aigner, R, Stanzel, S, Quehenberger, F, Aigner, RM, Marković, A Koljević, Janković, Milica, Jerković, V Miler, Paskaš, M, Pupić, G, Džodić, R, Popović, D, Fornito, MC, Familiari, D, Koranda, P, Polzerová, H, Metelková, I, Henzlová, L, Formánek, R, Buriánková, E, Kamínek, M, Thomson, WH, Lewis, C, Thomson, WH, O’Brien, J, James, G, Notghi, A, Huber, H, Stelzmüller, I, Wunn, R, Mandl, M, Fellner, F, Lamprecht, B, Gabriel, M, Fornito, MC, Leonardi, G, Thomson, WH, O’Brien, J, James, G, Hudzietzová, J, Sabol, J, and Fülöp, M

Published
2016
Full Text
View/download PDF

31. Finite Element Analysis Of Airfield Flexible Pavement

Author

Leonardi G.

Subjects
Impact, FEM, airfield pavement, aircraft landing, Abaqus, flexible pavement, Engineering (General). Civil engineering (General), TA1-2040
Abstract

The paper presents a numerical study of an aircraft wheel impacting on a flexible landing surface. The proposed 3D model simulates the behaviour of flexible runway pavement during the landing phase. This model was implemented in a finite element code in order to investigate the impact of repeated cycles of loads on pavement response.

Published
2014
Full Text
View/download PDF

37. Fractal Dimension for the Characterization of the Porosity of Asphalt Concretes

Author

Leonardi G.

Subjects
fractal geometry, porosity, mixture, aggregate, concrete, pavement, Engineering (General). Civil engineering (General), TA1-2040
Abstract

In the design of asphalt mixtures for paving, the choice of components has a remarkable importance, as requirements of quality and durability must be assured in use, guaranteeing adequate standards of safety and comfort.

Published
2010
Full Text
View/download PDF

43. [Optimal therapeutic management in the clinical journey of patients with heart failure]

Author

Ameri, P., Amico, A. F., Battagliese, A., Berra, S., Calabro, P., Candela, M., Clemenza, F., Desideri, G., Di Tano, G., Gallucci, F., Gardin, A., Iacoviello, M., Leonardi, G., Morgagni, R., Mortara, A., Palazzuoli, A., Paolillo, S., Filardi, P. P., Volpe, M., Ameri, P., Amico, A. F., Battagliese, A., Berra, S., Calabro', P., Candela, M., Clemenza, F., Desideri, G., Di Tano, G., Gallucci, F., Gardin, A., Iacoviello, M., Leonardi, G., Morgagni, R., Mortara, A., Palazzuoli, A., Paolillo, S., Filardi, P. P., and Volpe, M.

Subjects
Heart Failure, N-terminal pro-B-type natriuretic peptide, Stroke Volume, angiotensin receptor-neprilysin inhibitors, disease-modifying drug, heart failure with reduced ejection fraction, networking, sacubitril/valsartan, Heart failure with reduced ejection fraction, Angiotensin receptor-neprilysin inhibitor, Networking, Angiotensin Receptor Antagonists, Ventricular Dysfunction, Left, Disease-modifying drug, Quality of Life, Humans, Sacubitril/valsartan
Abstract

Heart failure (HF) is still characterized by high mortality rates, despite the progress achieved in terms of treatment options. With regard to the treatment of HF with reduced ejection fraction (HFrEF), the 2016 European Society of Cardiology guidelines included in the therapeutic algorithm the angiotensin receptor-neprilysin inhibitor class, whose efficacy in modifying patient prognosis has been extensively proven in many clinical studies. Sacubitril/valsartan, the only representative of this drug class, can effectively affect the natural history of HF, thus reducing cardiovascular mortality (sudden death and death due to worsening cardiac function), total mortality, as well as first and recurrent hospitalization events, by improving renal function, cardiac remodeling, functional capacity and the patient's health-related quality of life.The purpose of this article is to analyze the different phases of the journey of patients with HFrEF (first general practitioner consultation; admission to the emergency department and subsequent hospitalization; referral to a specialist HF clinic) and promotion of a networking approach involving the general practitioner, the hospital and the HF specialist based on common pre-defined diagnostic and therapeutic protocols, that meets patient needs at all stages of the disease (case-specific dosing assessment, drug titration before follow-up and prevention of adverse events).

Published
2020

44. Updated Italian Vertebrate Ichnology Reference List

Author

Antonelli M., Avanzini M., Belvedere M., Bernardi M., Ceoloni P., Citton P., Conti M. A., Dalla Vecchia F. M., D'Orazi Porchetti S., Gianolla P., Leonardi G., Manni R., Marchetti L., Mariotti N., Massari F., Mietto P., Muscio G., Palombo M. R., Panarello A., Petruzzelli M., Petti F. M., Pignatti J., Pillola G., Piubelli D., Raia P., Romano M., Ronchi A., Sacchi E., Sacco E., Salvador I., Santi S., Schirolli P., Valentini M., Wagensommer A., Zoboli D., Antonelli, M., Avanzini, M., Belvedere, M., Bernardi, M., Ceoloni, P., Citton, P., Conti, M. A., Dalla Vecchia, F. M., D'Orazi Porchetti, S., Gianolla, P., Leonardi, G., Manni, R., Marchetti, L., Mariotti, N., Massari, F., Mietto, P., Muscio, G., Palombo, M. R., Panarello, A., Petruzzelli, M., Petti, F. M., Pignatti, J., Pillola, G., Piubelli, D., Raia, P., Romano, M., Ronchi, A., Sacchi, E., Sacco, E., Salvador, I., Santi, S., Schirolli, P., Valentini, M., Wagensommer, A., and Zoboli, D.

Published
2020

48. BLITZ‐HF: a nationwide initiative to evaluate and improve adherence to acute and chronic heart failure guidelines.

Author

Gulizia, Michele Massimo, Orso, Francesco, Mortara, Andrea, Lucci, Donata, Aspromonte, Nadia, De Luca, Leonardo, Di Tano, Giuseppe, Leonardi, Giuseppe, Navazio, Alessandro, Pulignano, Giovanni, Colivicchi, Furio, Di Lenarda, Andrea, Oliva, Fabrizio, Pajes, G., Felici, A.R., Midi, P., Leonardi, G., Montana, G., Randazzo, V., and Guerri, E.

Subjects
HEART failure, MEDICAL personnel, VENTRICULAR ejection fraction, ECHOCARDIOGRAPHY
Abstract

Aims: To assess adherence to guideline recommendations among a large network of Italian cardiology sites in the management of acute and chronic heart failure (HF) and to evaluate if an ad‐hoc educational intervention can improve their performance on several pharmacological and non‐pharmacological indicators. Methods and results: BLITZ‐HF was a cross‐sectional study based on a web‐based recording system with pop‐up reminders on guideline recommendations used during two 3‐month enrolment periods carried out 3 months apart (Phase 1 and 3), interspersed by face‐to‐face macro‐regional benchmark analyses and educational meetings (Phase 2). Overall, 7218 patients with acute and chronic HF were enrolled at 106 cardiology sites. During the enrolment phases, 3920 and 3298 patients were included, respectively, 84% with chronic HF and 16% with acute HF in Phase 1, and 74% with chronic HF and 26% with acute HF in Phase 3. At baseline, adherence to guideline recommendations was already overall high for most indicators. Among acute HF patients, an improvement was obtained in three out of eight indicators, with a significant rise in echocardiographic evaluation. Among chronic HF patients with HF and preserved or mid‐range ejection fraction, performance increased in two out of three indicators: creatinine and echocardiographic evaluations. An overall performance improvement was observed in six out of nine indicators in ambulatory HF with reduced ejection fraction patients with a significant increase in angiotensin receptor–neprilysin inhibitor prescription rates. Conclusions: Within a context of an already elevated level of adherence to HF guideline recommendations, a structured multifaceted educational intervention could be useful to improve performance on specific indicators. Extending this approach to other non‐cardiology healthcare professionals, who usually manage patients with HF, should be considered. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

49. A global-scale screening of non-native aquatic organisms to identify potentially invasive species under current and future climate conditions

Author

Vilizzi, L., Copp, G.H., Hill, J.E., Adamovich, B., Aislabie, L., Akin, D., Al-Faisal, A.J., Almeida, D., Azmai, M.N.A., Bakiu, R., Bellati, A., Bernier, R., Bies, J.M., Bilge, G., Branco, P., Bui, T.D., Canning-Clode, J., Cardoso Ramos, H.A., Castellanos-Galindo, G.A., Castro, N., Chaichana, R., Chainho, P., Chan, J., Cunico, A.M., Curd, A., Dangchana, P., Dashinov, D., Davison, P.I., de Camargo, M.P., Dodd, J.A., Durland Donahou, A.L., Edsman, L., Ekmekçi, F.G., Elphinstone-Davis, J., Erős, T., Evangelista, C., Fenwick, G., Ferincz, Á., Ferreira, T., Feunteun, E., Filiz, H., Forneck, S.C., Gajduchenko, H.S., Gama Monteiro, J., Gestoso, I., Giannetto, D., Gilles A.S., Jr, Gizzi, F., Glamuzina, B., Glamuzina, L., Goldsmit, J., Gollasch, S., Goulletquer, P., Grabowska, J., Harmer, R., Haubrock, P.J., He, D., Hean, J.W., Herczeg, G., Howland, K.L., İlhan, A., Interesova, E., Jakubčinová, K., Jelmert, A., Johnsen, S.I., Kakareko, T., Kanongdate, K., Killi, N., Kim, J.-E., Kırankaya, Ş.G., Kňazovická, D., Kopecký, O., Kostov, V., Koutsikos, N., Kozic, S., Kuljanishvili, T., Kumar, B., Kumar, L., Kurita, Y., Kurtul, I., Lazzaro, L., Lee, L., Lehtiniemi, M., Leonardi, G., Leuven, R.S.E.W., Li, S., Lipinskaya, T., Liu, F., Lloyd, L., Lorenzoni, M., Luna, S.A., Lyons, T.J., Magellan, K., Malmstrøm, M., Marchini, A., Marr, S.M., Masson, G., Masson, L., McKenzie, C.H., Memedemin, D., Mendoza, R., Minchin, D., Miossec, L., Moghaddas, S.D., Moshobane, M.C., Mumladze, L., Naddafi, R., Najafi-Majd, E., Năstase, A., Năvodaru, I., Neal, J.W., Nienhuis, S., Nimtim, M., Nolan, E.T., Occhipinti-Ambrogi, A., Ojaveer, H., Olenin, S., Olsson, K., Onikura, N., O'Shaughnessy, K., Paganelli, D., Parretti, P., Patoka, J., Pavia R.T.B., Jr, Pellitteri-Rosa, D., Pelletier-Rousseau, M., Peralta, E.M., Perdikaris, C., Pietraszewski, D., Piria, M., Pitois, S., Pompei, L., Poulet, N., Preda, C., Puntila-Dodd, R., Qashqaei, A.T., Radočaj, T., Rahmani, H., Raj, S., Reeves, D., Ristovska, M., Rizevsky, V., Robertson, D.R., Robertson, P., Ruykys, L., Saba, A.O., Santos, J.M., Sarı, H.M., Segurado, P., Semenchenko, V., Senanan, W., Simard, N., Simonović, P., Skóra, M.E., Slovák Švolíková, K., Smeti, E., Šmídová, T., Špelić, I., Srėbalienė, G., Stasolla, G., Stebbing, P., Števove, B., Suresh, V.R., Szajbert, B., Ta, K.A.T., Tarkan, A.S., Tempesti, J., Therriault, T.W., Tidbury, H.J., Top-Karakuş, N., Tricarico, E., Troca, D.F.A., Tsiamis, K., Tuckett, Q.M., Tutman, P., Uyan, U., Uzunova, E., Vardakas, L., Velle, G., Verreycken, H., Vintsek, L., Wei, H., Weiperth, A., Weyl, O.L.F., Winter, E.R., Włodarczyk, R., Wood, L.E., Yang, R., Yapıcı, S., Yeo, S.S.B., Yoğurtçuoğlu, B., Yunnie, A.L.E., Zhu, Y., Zięba, G., Žitňanová, K., Clarke, S., Vilizzi, L., Copp, G.H., Hill, J.E., Adamovich, B., Aislabie, L., Akin, D., Al-Faisal, A.J., Almeida, D., Azmai, M.N.A., Bakiu, R., Bellati, A., Bernier, R., Bies, J.M., Bilge, G., Branco, P., Bui, T.D., Canning-Clode, J., Cardoso Ramos, H.A., Castellanos-Galindo, G.A., Castro, N., Chaichana, R., Chainho, P., Chan, J., Cunico, A.M., Curd, A., Dangchana, P., Dashinov, D., Davison, P.I., de Camargo, M.P., Dodd, J.A., Durland Donahou, A.L., Edsman, L., Ekmekçi, F.G., Elphinstone-Davis, J., Erős, T., Evangelista, C., Fenwick, G., Ferincz, Á., Ferreira, T., Feunteun, E., Filiz, H., Forneck, S.C., Gajduchenko, H.S., Gama Monteiro, J., Gestoso, I., Giannetto, D., Gilles A.S., Jr, Gizzi, F., Glamuzina, B., Glamuzina, L., Goldsmit, J., Gollasch, S., Goulletquer, P., Grabowska, J., Harmer, R., Haubrock, P.J., He, D., Hean, J.W., Herczeg, G., Howland, K.L., İlhan, A., Interesova, E., Jakubčinová, K., Jelmert, A., Johnsen, S.I., Kakareko, T., Kanongdate, K., Killi, N., Kim, J.-E., Kırankaya, Ş.G., Kňazovická, D., Kopecký, O., Kostov, V., Koutsikos, N., Kozic, S., Kuljanishvili, T., Kumar, B., Kumar, L., Kurita, Y., Kurtul, I., Lazzaro, L., Lee, L., Lehtiniemi, M., Leonardi, G., Leuven, R.S.E.W., Li, S., Lipinskaya, T., Liu, F., Lloyd, L., Lorenzoni, M., Luna, S.A., Lyons, T.J., Magellan, K., Malmstrøm, M., Marchini, A., Marr, S.M., Masson, G., Masson, L., McKenzie, C.H., Memedemin, D., Mendoza, R., Minchin, D., Miossec, L., Moghaddas, S.D., Moshobane, M.C., Mumladze, L., Naddafi, R., Najafi-Majd, E., Năstase, A., Năvodaru, I., Neal, J.W., Nienhuis, S., Nimtim, M., Nolan, E.T., Occhipinti-Ambrogi, A., Ojaveer, H., Olenin, S., Olsson, K., Onikura, N., O'Shaughnessy, K., Paganelli, D., Parretti, P., Patoka, J., Pavia R.T.B., Jr, Pellitteri-Rosa, D., Pelletier-Rousseau, M., Peralta, E.M., Perdikaris, C., Pietraszewski, D., Piria, M., Pitois, S., Pompei, L., Poulet, N., Preda, C., Puntila-Dodd, R., Qashqaei, A.T., Radočaj, T., Rahmani, H., Raj, S., Reeves, D., Ristovska, M., Rizevsky, V., Robertson, D.R., Robertson, P., Ruykys, L., Saba, A.O., Santos, J.M., Sarı, H.M., Segurado, P., Semenchenko, V., Senanan, W., Simard, N., Simonović, P., Skóra, M.E., Slovák Švolíková, K., Smeti, E., Šmídová, T., Špelić, I., Srėbalienė, G., Stasolla, G., Stebbing, P., Števove, B., Suresh, V.R., Szajbert, B., Ta, K.A.T., Tarkan, A.S., Tempesti, J., Therriault, T.W., Tidbury, H.J., Top-Karakuş, N., Tricarico, E., Troca, D.F.A., Tsiamis, K., Tuckett, Q.M., Tutman, P., Uyan, U., Uzunova, E., Vardakas, L., Velle, G., Verreycken, H., Vintsek, L., Wei, H., Weiperth, A., Weyl, O.L.F., Winter, E.R., Włodarczyk, R., Wood, L.E., Yang, R., Yapıcı, S., Yeo, S.S.B., Yoğurtçuoğlu, B., Yunnie, A.L.E., Zhu, Y., Zięba, G., Žitňanová, K., and Clarke, S.

Abstract

The threat posed by invasive non-native species worldwide requires a global approach to identify which introduced species are likely to pose an elevated risk of impact to native species and ecosystems. To inform policy, stakeholders and management decisions on global threats to aquatic ecosystems, 195 assessors representing 120 risk assessment areas across all six inhabited continents screened 819 non-native species from 15 groups of aquatic organisms (freshwater, brackish, marine plants and animals) using the Aquatic Species Invasiveness Screening Kit. This multi-lingual decision-support tool for the risk screening of aquatic organisms provides assessors with risk scores for a species under current and future climate change conditions that, following a statistically based calibration, permits the accurate classification of species into high-, medium- and low-risk categories under current and predicted climate conditions. The 1730 screenings undertaken encompassed wide geographical areas (regions, political entities, parts thereof, water bodies, river basins, lake drainage basins, and marine regions), which permitted thresholds to be identified for almost all aquatic organismal groups screened as well as for tropical, temperate and continental climate classes, and for tropical and temperate marine ecoregions. In total, 33 species were identified as posing a ‘very high risk’ of being or becoming invasive, and the scores of several of these species under current climate increased under future climate conditions, primarily due to their wide thermal tolerances. The risk thresholds determined for taxonomic groups and climate zones provide a basis against which area-specific or climate-based calibrated thresholds may be interpreted. In turn, the risk rankings help decision-makers identify which species require an immediate ‘rapid’ management action (e.g. eradication, control) to avoid or mitigate adverse impacts, which require a full risk assessment, and which are to be r

Published
2021

50. Dalla dichiarazione dello stato di emergenza alla legge di bilancio per il 2021: l’impatto normativo sui comuni

Author

Astolfo, R., Balducci, M., Bergonzini, C., Bertin, G., Billio, M., Bolgherini, S., Brambilla, P., Brigante, V., Brino, V., Bucci, V., Buonsante, N. I., Caldura, F., Campostrini, S., Canossi, G., Degni, M., Eisenberg, E., Ferrara, G., Ferri, A., Gabrielli, G., Gallo, G. M., Grassi, A., Lagravinese R., Laurenza E., Leonardi, G., Letterio, D., Luciani, E., Manzetti, V., Meneghelli, E., Menegus, G., Messina, P., Minervini, L. F., Morgia, A., Nardo, M. T., Pellizzari, S., Petrina, F., Porcelli, F., Porchia, S., Pupo, P., Resce, G., Rosa Salva, P. M., Scapinello, C., Sirtori, S., Tubertini, C., Turrin, M., Vermiglio, C., Vinella, A., Zantedeschi, M, Degni, M, Luciani, E, Luciani E., Astolfo, R., Balducci, M., Bergonzini, C., Bertin, G., Billio, M., Bolgherini, S., Brambilla, P., Brigante, V., Brino, V., Bucci, V., Buonsante, N. I., Caldura, F., Campostrini, S., Canossi, G., Degni, M., Eisenberg, E., Ferrara, G., Ferri, A., Gabrielli, G., Gallo, G. M., Grassi, A., Lagravinese R., Laurenza E., Leonardi, G., Letterio, D., Luciani, E., Manzetti, V., Meneghelli, E., Menegus, G., Messina, P., Minervini, L. F., Morgia, A., Nardo, M. T., Pellizzari, S., Petrina, F., Porcelli, F., Porchia, S., Pupo, P., Resce, G., Rosa Salva, P. M., Scapinello, C., Sirtori, S., Tubertini, C., Turrin, M., Vermiglio, C., Vinella, A., Zantedeschi, M, Degni, M, Luciani, E, and Luciani E.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results